Identification of potential plasma markers for hepatitis B virus‐related chronic hepatitis and liver fibrosis/cirrhosis
- 14 April 2022
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (8) , 3900-3910
Abstract
The aim of this study was to identify potential plasma biomarkers for hepatitis B virus (HBV)‐related liver diseases. High‐throughput transcriptome sequencing analysis was performed on five patients with chronic hepatitis B (CHB), five patients with HBV‐associated liver fibrosis/liver cirrhosis (LF/LC), and four healthy participants. By short time‐series expression miner and functional analysis, aquaporin 1 (AQP1), dystroglycan 1 (DAG1), and hemoglobin subunit beta (HBB) were identified as potential biomarkers. Immunohistochemical analysis revealed that the expression levels of AQP1, DAG1, and HBB were upregulated in the three groups. Subsequent enzyme‐linked immunosorbent assay tests on the training cohort ( n = 150) indicated that the plasma levels of AQP1 and DAG1 were highest in LF/LC patients, followed by those in CHB patients, and the lowest in healthy controls. APAD model, a diagnostic panel incorporating age, platelet, AQP1, and DAG1 levels, exhibited the strongest stratification ability to distinguish LF/LC patients from CHB patients, and to differentiate CHB patients from healthy controls. Furthermore, the diagnostic accuracies of the biomarkers and APAD model were verified in an independent cohort consisting of 230 participants. In conclusion, both AQP1 and DAG1 have good diagnostic values and APAD model greatly enhances the diagnostic accuracy for HBV‐related hepatic diseases.Keywords
Funding Information
- Hebei Provincial Key Research Projects (No.19277779D)
This publication has 32 references indexed in Scilit:
- Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar CholangiocarcinomaTechnology in Cancer Research & Treatment, 2016
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International, 2015
- Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver CirrhosisGut and Liver, 2015
- Analysis of aquaporin expression in liver with a focus on hepatocytesHistochemistry and Cell Biology, 2015
- Non-invasive diagnosis of liver fibrosis and cirrhosisWorld Journal of Gastroenterology, 2015
- Correlation of Deregulated Like-Acetylglucosaminyl Transferase and Aberrant α-Dystroglycan Expression With Human Tongue Cancer MetastasisJournal of Oral and Maxillofacial Surgery, 2014
- Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinomaClinical Proteomics, 2013
- Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liverMedical Molecular Morphology, 2013
- Aquaporin-1 Promotes Angiogenesis, Fibrosis, and Portal Hypertension Through Mechanisms Dependent on Osmotically Sensitive MicroRNAsThe American Journal of Pathology, 2011
- Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgeryGut, 2008